Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Receiving Standard Chemotherapy Regimens

Clinical Trial ID NCT02537418

PubWeight™ 1.58‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02537418

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Advances in immunotherapy for melanoma. BMC Med 2016 0.83
2 Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel? ESMO Open 2016 0.77
Next 100